Aqueous rechargeable zinc ion batteries are considered a promising candidate for large‐scale energy storage owing to their low cost and high safety nature. A composite material comprised of H2V3O8 nanowires (NWs) wrapped by graphene sheets and used as the cathode material for aqueous rechargeable zinc ion batteries is developed. Owing to the synergistic merits of desirable structural features of H2V3O8 NWs and high conductivity of the graphene network, the H2V3O8 NW/graphene composite exhibits superior zinc ion storage performance including high capacity of 394 mA h g−1 at 1/3 C, high rate capability of 270 mA h g−1 at 20 C and excellent cycling stability of up to 2000 cycles with a capacity retention of 87%. The battery offers a high energy density of 168 W h kg−1 at 1/3 C and a high power density of 2215 W kg−1 at 20 C (calculated based on the total weight of H2V3O8 NW/graphene composite and the theoretically required amount of Zn). Systematic structural and elemental characterization confirm the reversible Zn2+ and water cointercalation electrochemical reaction mechanism. This work brings a new prospect of designing high‐performance aqueous rechargeable zinc ion batteries for grid‐scale energy storage.
BackgroundTo determine appropriate timing of an adaptive radiation therapy (ART) replan by evaluating anatomic and dosimetric changes of target volumes and organs at risk (OARs) during intensity-modulated radiation therapy (IMRT) for nasopharyngeal carcinoma (NPC).MethodsNineteen NPC patients were recruited. Each patient had repeat computed tomography (CT) scans after each five fractions and at treatment completion. Automatic re-contouring the targets and OARs by using deformable registration algorithm was conducted through CT-CT fusion. Anatomic changes were assessed by comparing the initial CT and repeated CT. Hybrid plans with re-contouring were generated and the dose-volume histograms (DVH) of the hybrid plan and the original plan were compared.ResultsProgressive volume reductions in gross target volume for primary disease (GTVnx), gross target volume for involved lymph nodes (GTVnd), and parotids were observed over time. Comparing with the original plan, each hybrid plan had no significant difference in homogeneity index (HI) for all the targets. Some parameters for planning target volumes for primary disease and high-risk clinical target volume (PTVnx and PTV1, respectively) improved significantly, notably starting from the 10th fraction. These parameters included mean dose (Dmean), dose to 95 % of the volume (D95), percentage of the volume receiving 95 % of the prescription dose (V95), and conformity index (CI) for PTVnx, and Dmean, D95, and CI for PTV1. The dosimetric parameters for PTVnd remained the same in general except for D95 and V95 which had significant improvement at specific time points; whereas for PTV2, similar trend of dosimetric changes was also observed. Dose to some OARs increased significantly at some time points.ConclusionsThere were significant anatomic and dosimetric changes in the targets and OARs. The target dose coverage in the hybrid plans did not get worse, but overdose occurred in some critical structures. Significant dosimetric changes should be considered as a trigger point at which ART replanning is indicated. D95/V95/CI for PTV2, Dmax for the brain stem, spinal cord, right eyeball and left lens, and Dmean/V30 for the parotids and glottis were taken into account for predicting the need for ART. Two replans at the 5th and 15th fractions were suggested.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.